comparemela.com

Latest Breaking News On - Chief executive officer vas narasimhan - Page 1 : comparemela.com

Novartis Raises Forecast as Sales of New Blockbusters Climb

Novartis Raises Forecast as Sales of New Blockbusters Climb
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Switzerland
Zurich
Züsz
Swiss
Giovanni-caforio
Joerg-reinhardt
Novartis
Bristol-myers-squibb-co
Roche-holding
Chief-executive-officer-vas-narasimhan
Bristol-myers-squibb
Swiss-pharma-giants-plot-different-paths

Novartis Surges After Forecast Boost Beats Expectations

Novartis Surges After Forecast Boost Beats Expectations
swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.

Switzerland
Swiss
Harry-kirsch
Giovanni-caforio
Joerg-reinhardt
Peter-welford
Bristol-myers-squibb-co
Novartis
Bloomberg
Chief-financial-officer-harry-kirsch
Chief-executive-officer-vas-narasimhan
Bristol-myers-squibb

Big Pharma Targets Smaller Companies With Megadeals Out of Favor

Big Pharma Targets Smaller Companies With Megadeals Out of Favor
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Switzerland
France
French
Swiss
Emma-walmsley
Wouter-joustra
Johnson
Alcon-inc
Pfizer-inc
Jpmorgan-health-conference
Eli-lilly-co
Sandoz-group

Big Pharma Targets Smaller Companies With Megadeals Out of Favor

Some drugmakers are doubling down on prescription medicines, shedding businesses they view as peripheral.

Switzerland
France
Swiss
French
Wouter-joustra
Emma-walmsley
Eli-lilly-co
Alcon-inc
Bloomberg
Inhibrx-inc
Sandoz-group
Haleon-plc

Novartis Shares Drop on Weak Prostate Cancer Drug Sales

Novartis AG shares slumped after the drugmaker reported earnings that came short of analysts’ estimates on weak revenue from Pluvicto, a prostate cancer treatment that faced supply constraints.

Argentina
Switzerland
Swiss
James-cone
Guy-johnson
Kriti-gupta
Bloomberg
Intron-health
Roche-holding
Bloomberg-television
Medicines-co
Novartis

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.